Levocabastin

Levocabastine, the active ingredient in Levocabastine, is a H1 receptor antagonist presented as an ophthalmic solution for ocular use. It is indicated for allergic conjunctivitis, seasonal allergic eye disease, and ocular itching due to allergy, and is available over‑the‑counter in the EU.

GNH USA supplies Levocabastine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Levocabastine is an ocular antihistamine used to manage allergic eye conditions.

- Allergic conjunctivitis: reduces redness, itching and swelling of the conjunctiva. - Seasonal allergic eye disease: alleviates symptoms triggered by pollen or seasonal allergens. - Ocular itching due to allergy: provides rapid relief of itch and discomfort.

Levocabastine may cause ocular or systemic adverse reactions, although most are mild and transient.

Common Side Effects: - Burning sensation: mild transient eye burning after instillation. - Stinging: brief stinging feeling in the eye. - Redness: mild conjunctival redness. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Allergic contact dermatitis: localized skin reaction around the eye. - Corneal ulceration: rare ulcer formation on the cornea. - Anaphylaxis: extremely rare systemic allergic reaction.

When using Levocabastine ophthalmic solution, consider the following precautions to ensure safe and effective use.

- Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: unknown; weigh benefits against potential risks. - Contact lenses: remove lenses before instillation and wait before reinserting. - Concomitant eye medications: avoid simultaneous use; administer other drops at least 5 minutes apart. - Allergic history: assess for known hypersensitivity to antihistamines or formulation components. - Store at room temperature: keep below 25 °C, protect from light and moisture in the original container.

Levocabastine may interact with other ophthalmic agents or systemic drugs.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): potential additive antihistaminic effects may increase ocular irritation. - Other H1‑antagonist eye drops: combined use can enhance local side effects.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may affect tear film stability. - Topical corticosteroids: monitor for increased intra‑ocular pressure. - Systemic antihistamines: may increase overall antihistaminic burden.